Christopher Sullivan to Prognosis
This is a "connection" page, showing publications Christopher Sullivan has written about Prognosis.
Connection Strength
0.152
-
Fitzpatrick TH, Magister MJ, Browne JD, Waltonen JD, Henderson BB, Patwa HS, Sullivan CA. Impact of outcomes data on the management of postoperative hypocalcemia in head and neck endocrine surgery patients. Am J Otolaryngol. 2020 Jul - Aug; 41(4):102477.
Score: 0.130
-
Goguen LA, Posner MR, Norris CM, Tishler RB, Wirth LJ, Annino DJ, Gagne A, Sullivan CA, Sammartino DE, Haddad RI. Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Otolaryngol Head Neck Surg. 2006 Jun; 134(6):916-22.
Score: 0.012
-
Haddad R, Tishler RB, Norris CM, Mahadevan A, Busse P, Wirth L, Goguen LA, Sullivan CA, Costello R, Case MA, Posner MR. Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment. Oncologist. 2003; 8(1):35-44.
Score: 0.010